Showing posts with label Emergency. Show all posts
Showing posts with label Emergency. Show all posts

Tuesday, September 17, 2013

Emergency Room RT Consult

The following is an ideal emergency room RT Consult, or aerosolized medication protocol for ER, that we have been working on. If anyone has suggestions to make this even better, please feel free to suggest.


For a printable copy of this protocol, click here.





EMERGENCY ROOM RESPIRATORY THERAPY CONSULT (RT CONSULT)

Protocol Content:


1. Scope: A Licensed Registered Respiratory Therapist (RRT) or Certified Respiratory Therapist (CRT) who has successfully completed and passed all competencies related to patient assessment and protocols. Although respiratory students and assistants may perform medicated aerosol therapy, they may not adjust therapy per protocol.


2. Emergency Room Aerosolized Medication Protocol


A. When a physician, physician’s assistant, RN, or RT orders RT Consult or RT to assess and treat, the RCP will be paged for a RT Consult. The RT may initiate this protocol working within the following guidelines.


B. Upon receiving the order, the respiratory therapist will assess patient and select appropriate therapy and medication.


C. The following conditions are accepted indications for bronchodilator therapy:




  • a. Bronchospasm/ wheezing

  • b. Asthma/ reactive airway disease

  • c. Diminished lung sounds

  • d. COPD

  • e. Prolonged expiratory phase

  • f. Obstructive defects of PFT

  • g. Impaired mucous clearance


D. B. Medications available per protocol:



  • a. Albuterol 0.25-0.5cc

  • b. Duoneb 1 unit dose vial

  • c. Atrovent 1 unit dose vial

  • e. Xoponex 0.63-1.25mg

  • f. Albuterol MDI



E. The following assessment and chart findings will be evaluated and documented as appropriate:



  • a. Vital signs (HR, RR, BP)

  • b. Current FiO2

  • c. Pulse oximetry

  • d. PEFR (if indicated)

  • e. Patient assessment results (lung sounds, work-of-breathing, cough, secretions)


F. Peak Expiratory Flow Rates (PEFR) will be done on asthmatics before and after the initial treatment according to the patient’s tolerance to perform the maneuver, or this will be performed as soon as patient is able.


G. Following an initial assessment, an initial treatment will be given to patient’s who meet the indications for therapy. If patient does not demonstrate improvement in PEFR, relief in Dyspnea or reduction in expiratory rhonchi or wheezing, the treatment may be repeated. If necessary, a third treatment may also be given.


H. If there is no improvement after repeated treatments, the physician will be informed the patient is not responding to therapy. Further therapy will be given only with physician notification.


I. If respiratory therapy determines patient would benefit from a MDI bronchodilator for home use, and the patient meets the criteria for MDI use, an Albuterol MDI may be administered to patient, and patient will be instructed on correct use of this MDI. The recommended dose and frequency is Q4-6 hours as needed.


J. Criteria for MDI use:



  • 1. Can physically perform the maneuver.

  • 2. Can follow directions.

  • 3. Is cooperative and alert.

  • 4. Can take a slow deep inspiration.

  • 5. Can hold breath for at least five seconds.

  • 6. Is able to perform a return demonstration.

  • 7. Respiratory rate less than or greater than= 25


3. Documentation:


A. Initial Assessment:


1. The respiratory therapist will write the order in the patients chart including medication, dose and frequency per RT Consult if the ordering physician did not already do so.


2. Initial orders written by the physician do not have to be rewritten by the respiratory therapist unless clarification or adjustments are required.


3. All therapy will be documented in the computerized charting system.


B. Re-assessments:


1. All patients will be assessed with every treatment to determine the patient’s current pulmonary status and effectiveness of the aerosol therapy.


2. Adjustments of the patient’s therapy will be determined objectively by changes in the monitored parameters.


REFERENCES:


1. Spectum Health (2005) Aerosolized Medication Protocol, Grand Rapids: Spectrum Health.


2. Northern Michigan Hospital (2004) Bronchodilator Protocol, Petosky, MI: Northern Michigan Hospital.


3. Covenant Health Care (2005) Respiratory Therapy Consult, Saginaw, MI: Covenant Health Care.


4. “Guidelines for Preparing a Respiratory Therapy Protocol.” Retrieved August 23, 2007, from http://www.aarc.org/members_area/resources/protocol_guidelines.html
5. “Respiratory Therapy Protocols.” Retrieved August 4, 2007, from http://www.st.alexius.org/about_stas/services/Resp_Care/protocols.asp?printable=1







Word of the dayAttenuate: To make thinner or weaker; to make slender; to rarify; to enervate

A few stupid doctor’s orders is all it takes to attenuate my energy supply.




Monday, September 16, 2013

Research Activities, May 2010: Emergency Medicine: Emergency department treatment of asthma with systemic corticosteroids is not always timely


Emergency Medicine
Emergency department treatment of asthma with systemic corticosteroids is not always timely


Each year, there are 2 million visits to emergency departments (EDs) for acute asthma attacks. Use of systemic corticosteroids (SCs) within 1 hour of ED arrival significantly improves pulmonary function and reduces the odds of hospital admission by 60 percent. However, not all asthma patients receive this treatment and, if they do, the medication may be given late in the course of the ED visit. The researchers identified 3,798 patients with acute asthma in 62 urban EDs located in 23 States. They analyzed clinical data to determine if patients had received SCs in a timely manner, specifically within 1 hour or less.


The majority of patients (67.4 percent) received SC treatment in the ED. However, more than half of treated patients (51.5 percent) got SCs more than an hour after their arrival time, with a median door-to-SC time of 62 minutes. ED physicians appropriately administered SCs to patients with more severe episodes (i.e., history of intubation for asthma, higher respiratory rate, and lower oxygen saturation). However, nonmedical factors associated with delayed SC treatment concerned the researchers. For example, patients with delayed SC treatment were more likely to be women, 40 years of age and older, and have a longer duration of symptoms.


Delayed patients also had longer ED stays and the likelihood of a delay in treatment was increased during peak ED hours. Patients who did not receive SCs were more likely to be discharged from the ED. The study was supported in part by the Agency for Healthcare Research and Quality (HS13099).


See “Factors associated with delayed use or nonuse of systemic corticosteroids in emergency department patients with acute asthma,” by Chu-Lin Tsai, M.D., Sc.D., Brian H. Rowe, M.D., MSc., Ashley F. Sullivan, M.S., M.P.H., and Carlos A. Camargo Jr., M.D., Dr.P.H., in the October 2009 Annals of Allergy, Asthma & Immunology 103, pp. 318-324.


open here please:
Research Activities, May 2010: Emergency Medicine: Emergency department treatment of asthma with systemic corticosteroids is not always timely